| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.082 | 0.1 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.081 | 0.1 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.1 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |